Skip to content
Review

C-reactive protein–triglyceride–glucose index and advanced cardiovascular-kidney-metabolic syndrome in middle-aged and older adults: A cross-population study

Oct 2026 · Journal of the Renin-Angiotensin-Aldosterone System · 0 citations · 36 references

Abstract

Cardiovascular–kidney–metabolic (CKM) syndrome integrates metabolic risk, kidney dysfunction and cardiovascular disease. The C-reactive protein–triglyceride–glucose index (CTI) combines inflammatory, lipid and glycaemic measures, but its association with advanced CKM across populations remains unclear. Cross-sectional analyses included adults aged ≥45 years from NHANES 2001–2010 and the 2011 and 2015 CHARLS waves. NHANES included 6290 participants from five consecutive two-year cycles with positive fasting-subsample weights. CHARLS included 19,347 observations from 13,867 participants; models adjusted for survey wave, with standard errors clustered by participant. CTI was examined continuously, per cohort-specific SD, by quartiles and with three-knot restricted cubic splines. Analyses included core and expanded models, sensitivity analyses and comparisons of concurrent discrimination. Core-model odds ratios per one-unit higher CTI were 1.76 (95% CI, 1.57–1.98) in NHANES and 2.90 (2.72–3.10) in CHARLS, attenuating to 1.50 (1.30–1.72) and 1.37 (1.26–1.49), respectively, after expanded adjustment. Sensitivity estimates remained positive. Overall spline associations were significant; non-linearity was absent in NHANES (P = 0.384) but present in CHARLS (P = 0.0039). Higher CTI was cross-sectionally associated with prevalent advanced CKM. Shared measurement domains and contemporaneous assessment limit causal and prospective interpretation, and the clinical value of CTI remains uncertain.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.